<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01845168</url>
  </required_header>
  <id_info>
    <org_study_id>S-20120034</org_study_id>
    <nct_id>NCT01845168</nct_id>
  </id_info>
  <brief_title>Prevention of Gastric Ulcer Bleeding by Using &quot;Computer-alert&quot; in General Practice</brief_title>
  <official_title>Prevention of Peptic Ulcer Bleeding Related to the Use of NSAIDs and Aspirin by Using &quot;Computer-alert&quot; - a Randomized Study in General Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Region of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate if a computerised decision-support tool used in
      general practice, can reduce the frequency of peptic ulcer bleeding related to the use of
      NSAIDs (Non-Steroidal-antiinflammatory-drug) and ASA( Acetylsalicylic acid) .

      On the basis of &quot;The Danish general medical database&quot; it is possible to develope a
      computerised decision-support tool, which enables the general practitioner (GP) in a &quot;pop-up&quot;
      window to get information on each patients risk-factors, when prescribing NSAID and aspirin
      to a patient at risk. This will give the general practitioner the oppurtunity to choose a
      different type of preparation or prescribe ulcer-preventive medicine at the same time.

      The decision-support tool will be tested in a randomized trial among general practitioners.
      The aim is to reduce the occurence of peptic ulcer bleeding. The expected outcome is a
      reduction in half of the total numbers of peptic ulcers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The background of the study is that NSAIDs and Aspirins increase the risk of peptic ulcer
      bleeding. On average 1-2% of patients using NSAID and Aspirin will develope gastric ulcer
      bleeding. But for patients with one or more risk-factors, the risk increases to 9% per 6
      months. The mortality in this case is 10-15%. Approximately 3200 patients are admitted to the
      hospital with bleeding ulcer annually in Denmark.

      Danish investigations have shown that 80% of all peptic ulcer bleedings admitted to hospital
      are related to the use of NSAID or Aspirin.

      The consumption of NSAID and Aspirin is large. A third of people over 60 are treated within a
      year with these preparations. The risk of developing gastric ulcer related to NSAID and
      Aspirin can be reduced by concomitant therapy with antacids. Several studies have shown that
      only 20-30% of patients with risk-factors receive ulcer preventive medicine.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient outcome: The number of hospitalizations due to bleeding ulcer complication.</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient outcome: The number of uncomplicated ulcer diagnosed by endoscopy.</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Prescription changes: How often the GP refrains the ASA/NSAID-treatment because of the risk-information and the computer-alert</measure>
    <time_frame>one year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Prescription changes: The number of patients with riskfactors, who will recieve a prescription of ulcer preventive medicine</measure>
    <time_frame>one year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Prescription changes: general changes in the frequency of NSAID ordinations</measure>
    <time_frame>one year</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Bleeding Peptic Ulcer</condition>
  <arm_group>
    <arm_group_label>Computer-alert</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 arm study active group: 'A computer alert which pops up when the GP prescribes NSAID/ASA to a patient with risk-factors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controlgroup, normal procedures</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control-group: GP working in normal procedures</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Computer-alert</intervention_name>
    <description>A computer-alert which is activated when the physician is making a prescription for ASA or NSAID. Only for patients with riskfactors such as: Age over 60, males-gender, NSAID and ASA in kombination, Adenosine-diphosphate-inhibitor (ADP-inhibitor), blood-thinning medicine, Selective serotonin reuptake-inhibitor (SSRI) and steroids</description>
    <arm_group_label>Computer-alert</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A computer alerts which pops up when the GP presribes NSAID/ASA to a patient with risk-factors</intervention_name>
    <description>A computer-alert which is activated when the physician is making a prescription for ASA or NSAID. Only for patients with riskfactors such as: Age over 60, males-gender, NSAID and ASA in combination, ADP-inhibitor, bloodthinning medicine, SSRI, and steroids</description>
    <arm_group_label>Computer-alert</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Computer-alert</intervention_name>
    <arm_group_label>Computer-alert</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  General practitioners in the Region of Southern Denmark which are linked to Danish
             General Medical Database for minimum 6 months

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johanna Petersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Afdeling for medicinske mavetarmsygdomme, Odense Universitetshospital.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jane M Hansen, MD , Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Afdeling for Medicinske mavetarmsygdomme</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johanna M Petersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Afdeling for medicinske mavetarmsygdomme, Odense Universitetshospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johanna Petersen, MD</last_name>
    <email>jmpetersen@health.sdu.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jane MÃ¸ller Hansen, MD, Ph.D</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Afdeling for medicinske mavetarmsygdomme - Odense Universitetshospital</name>
      <address>
        <city>Odense</city>
        <state>Funen</state>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Petersen, MD</last_name>
      <phone>0045 24379220</phone>
      <email>jmpetersen@health.sdu.dk</email>
    </contact>
    <investigator>
      <last_name>Johanna Petersen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Afdeling for medicinske mavetarmsygdomme, Odense Universitetshospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johanna Petersen</last_name>
      <email>jmpetersen@health.sdu.dk</email>
    </contact>
    <investigator>
      <last_name>Johanna Petersen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2013</study_first_submitted>
  <study_first_submitted_qc>April 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2013</study_first_posted>
  <last_update_submitted>October 28, 2013</last_update_submitted>
  <last_update_submitted_qc>October 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Johanna Petersen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Bleeding peptic ulcer</keyword>
  <keyword>NSAID and Aspirin</keyword>
  <keyword>Computer-alert</keyword>
  <keyword>General practitioner</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

